ORIENT BIO Inc. (KRX:002630)

ORIENT BIO Revenue

ORIENT BIO had revenue of 17.21B KRW in the quarter ending December 31, 2021, with 21.77% growth. This brings the company's revenue in the last twelve months to 59.09B, up 19.53% year-over-year. In the fiscal year ending March 31, 2021, ORIENT BIO had annual revenue of 52.02B with 39.79% growth.

• Revenue (ttm): 59.09B
• Revenue Growth: +19.53%
• P/S Ratio: 0.88
• Revenue / Employee: 472.73M
• Employees: 125
• Market Cap: 51.75B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2021	52.02B	14.81B	39.79%
Mar 31, 2020	37.21B	6.84B	22.52%
Mar 31, 2019	30.37B	4.75B	18.53%
Mar 31, 2018	25.62B	-83.39B	-76.50%
Mar 31, 2017	109.02B	3.97B	3.78%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2021

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error